Your browser doesn't support javascript.
loading
Significance of Early Visual Responses to Bevacizumab for Macular Edema in Branch Retinal Vein Occlusion
Journal of the Korean Ophthalmological Society ; : 937-946, 2017.
Artículo en Coreano | WPRIM | ID: wpr-194882
ABSTRACT

PURPOSE:

To determine whether early visual acuity response to intravitreal bevacizumab in macular edema (ME) secondary to branch retinal vein occlusion (BRVO) is associated with 12-month follow-up outcome.

METHODS:

Sixty treatment-naïve patients (60 eyes) with ME secondary to BRVO treated with intravitreal bevacizumab (1.25 mg) were retrospectively included. Initially, all patients were injected monthly to achieve fluid resolution and followed up with a pro re nata regimen for at least 12 months. The relationship between early (month 1) and late (month 12) visual acuity response (mean change from baseline in best-corrected visual acuity [BCVA]; categorized improvement [<1, 1–3, or ≥3 logMAR lines in BCVA]) was explored.

RESULTS:

The proportions of eyes with <1, 1-<3, and ≥3-line improvements at 1 month were 19 eyes (31.7%), 17 eyes (28.3%), and 24 eyes (40%), respectively. Within each of the three response categories, the mean BCVA change from baseline at 12 months and onward did not vary by more than 1 line from the observed mean BCVA improvement at 1 month. Inter-cohort differences across the three response categories in mean BCVA change from baseline were statistically significant at each time point. Early BCVA response at 1 month showed significant associations with ≥3 line improvement and BCVA response at 12 months in multiple logistic and linear regression analyses.

CONCLUSIONS:

Early BCVA responses to bevacizumab are associated with subsequent responses over the entire 12-month duration of treatment.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Vena Retiniana / Retinaldehído / Oclusión de la Vena Retiniana / Agudeza Visual / Modelos Lineales / Edema Macular / Estudios Retrospectivos / Estudios de Seguimiento / Bevacizumab Tipo de estudio: Estudio observacional / Estudio pronóstico / Factores de riesgo Límite: Humanos Idioma: Coreano Revista: Journal of the Korean Ophthalmological Society Año: 2017 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Vena Retiniana / Retinaldehído / Oclusión de la Vena Retiniana / Agudeza Visual / Modelos Lineales / Edema Macular / Estudios Retrospectivos / Estudios de Seguimiento / Bevacizumab Tipo de estudio: Estudio observacional / Estudio pronóstico / Factores de riesgo Límite: Humanos Idioma: Coreano Revista: Journal of the Korean Ophthalmological Society Año: 2017 Tipo del documento: Artículo